What's happening in clinical trials right now?
This event focused on clinical trials for mitochondrial disease (mito). It was led by Dr Serge Geara, a neurologist and mitochondrial disease fellow at NeuRA.
This event was recorded on Saturday 1 November 2025, during the Mito Community Summit. Visit our website to listen to or read about this event.
Related resources:
Listen to the audio
Read a summary of the event here
This summary has been automatically generated.
- Dr. Serge Geara, a neurologist focusing on mitochondrial diseases, discusses the current state of clinical trials for mitochondrial disease, with dozens of trials happening worldwide and more new therapies in development 00:58.
- Mitochondrial diseases are complex, with multiple mutations affecting people differently, and symptoms can vary greatly between individuals, making it challenging to find effective treatments 02:45.
- Several medications are being researched, including Elamipretide, which stabilises the mitochondrial membrane, and Bio 101, which targets the map kynise pathway to improve muscle physiology 05:33.
- Other potential agents, such as KL133, are being investigated for their ability to control lactic acidosis and increase energy levels, with a potential trial awaiting ethics approval 09:08.
- Researchers are exploring various novel agents, including Ren 001, which aims to train muscles to become better and potentially address muscle symptoms in mitochondrial disease 11:05.
- Another agent, NV354, is being investigated for its potential to activate the citric acid cycle and increase ATP production, with promising pre-clinical results 12:17.
- Gene therapy is also being explored as a potential treatment for mitochondrial diseases, using techniques such as viral vectors to deliver genetic material to specific cells 13:03.
- The Mito Foundation is involved in a natural history study of mitochondrial diseases, collecting samples and clinical information from patients to better understand the progression of the disease and identify potential biomarkers 16:08.
- Researchers are investigating various medications, including Zagosiguat, which aims to prevent further tissue damage by keeping blood vessels open, and are encouraging patients to ask their doctors about potential trials 17:42.
Disclaimer: Resources provided by the Australian Mitochondrial Disease Foundation Limited (Mito Foundation), offers general information and is not a substitute for medical advice. It is essential to assess the suitability of the content for your individual circumstances and make decisions based on your medical condition. The information's accuracy is subject to change, and we do not guarantee ongoing currency or availability. While efforts are made to ensure accuracy, Mito Foundation is not obligated to provide updated information. The copyright for this document and its content belongs to, or is licensed to, Mito Foundation, and reproduction without prior written consent is prohibited.
More Videos
Mitochondrial Donation – UK Results and What’s Next
View VideoThis event focused on the diagnosis of mitochondrial disease (mito). It was led by Mia Bell, the co-chair of Mito Foundation’s Mito Community Advisory Panel and Clare Stuart, Mito Foundation’s Advocacy and Engagement Manager. This webinar features Professor Mary Herbert, a world expert and a leader of the UK’s mitochondrial donation program. Prof Herbert was the lead author of the key publication reporting reproductive outcomes of mito donation outcomes in the UK and has now joined he mitoHOPE team to continue research on mitochondrial donation in Australia.. The webinar also includes Professor John Christodoulou, who is leading the clinical stream of mitoHOPE and Professor Sir Doug Turnbull, part of the University of Newcastle team from the UK. This event was recorded on Tuesday 19 August 2025. It is available to watch, listen or read about.
The mitoHOPE program, explaining mitochondrial donation video link
During the event, there wasn’t time to answer every question. You can find the additional Q&A that was shared afterwards at the bottom of this page.
Powering progress: The future of clinical trials for mito
View VideoMito Foundation and Research Australia hosted this event to discuss increasing clinical trials for mitochondrial disease (mito) in Australia. Speakers included people with lived experience and leaders in the field. Together, they brought wide-ranging life experiences and professional insights. They discussed:
- the clinical trial process
- why some trials not coming to Australia and what can we do to change this
- how we can work together to shape the future of clinical trials.
The event was recorded on 16 April 2025.
Learn more about our plan to increase clinical trials for mito in Australia.